Research Centre for Plant Growth and Development, School of Biological and Conservation Sciences, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa.
J Ethnopharmacol. 2010 Apr 21;128(3):555-60. doi: 10.1016/j.jep.2010.01.057. Epub 2010 Feb 4.
Acacia nilotica subsp. kraussiana was reported in African traditional medicine for the treatment of various ailments. Isolation of an active compound in this study from the bark extract may lead to the validation of its efficiency as a traditional crude drug.
This study aimed to isolate active compound(s) from an ethyl acetate bark extract of Acacia nilotica subsp. kraussiana and to investigate some of its biological activity.
The isolation process was carried out using bioassay-guided fractionation. The isolated compound was tested for antibacterial activity using the micro-dilution assay; anti-inflammatory activity using the COX-1 and COX-2 assays and investigated for inhibitory effect against acetylcholinesterase using the microplate assay.
A new bioactive compound was isolated and identified as a cassane diterpene, niloticane. Niloticane showed antibacterial activity against Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus with MIC values of 4 and 8microg/mL, respectively. With Gram-negative bacteria, niloticane showed weak activity. MIC values obtained were 16 and 33microg/mL against Klebsiella pneumonia and Escherichia coli, respectively. In the cyclooxygenase test, niloticane possessed activity with IC50 values of 28 and 210microM against COX-1 and COX-2, respectively. IC50 values observed with indomethacin (positive control) were 3.6microM for COX-1 and 189microM for COX-2. In the acetylcholinesterase test, niloticane showed anti-cholinesterase activity with an IC50 value of 4microM. IC50 values obtained by the galanthamine (positive control) was 2.0microM.
The results obtained support the traditional uses of the bark of Acacia nilotica subsp. kraussiana in African traditional medicine for the treatment of some ailments that relate to microbial diseases, inflammation and central nervous system disorders.
在非洲传统医学中,金合欢亚种。Kraussiana 被报道用于治疗各种疾病。从树皮提取物中分离出本研究中的活性化合物可能会验证其作为传统粗药的功效。
本研究旨在从金合欢亚种的乙酸乙酯树皮提取物中分离出活性化合物,并研究其一些生物学活性。
采用生物测定指导的分步分离法进行分离过程。用微量稀释法测定分离出的化合物的抗菌活性;用 COX-1 和 COX-2 测定法测定抗炎活性;用微量板法测定对乙酰胆碱酯酶的抑制作用。
分离并鉴定出一种新的生物活性化合物,即贝壳杉二萜 niloticane。Niloticane 对革兰氏阳性菌枯草芽孢杆菌和金黄色葡萄球菌具有抗菌活性,MIC 值分别为 4 和 8μg/ml。对革兰氏阴性菌,niloticane 表现出较弱的活性。对肺炎克雷伯菌和大肠杆菌的 MIC 值分别为 16 和 33μg/ml。在环氧化酶试验中,niloticane 对 COX-1 和 COX-2 的 IC50 值分别为 28 和 210μM。阳性对照吲哚美辛的 IC50 值分别为 3.6μM 和 189μM。在乙酰胆碱酯酶试验中,niloticane 表现出抗胆碱酯酶活性,IC50 值为 4μM。阳性对照加兰他敏的 IC50 值为 2.0μM。
研究结果支持非洲传统医学中使用金合欢亚种的树皮来治疗与微生物疾病、炎症和中枢神经系统紊乱有关的一些疾病的传统用途。